As per reports, Walgreen Boots Alliance (WBA) recent announced that all individuals over the age of 18 can now receive a Moderna, Pfizer, or Johnson & Johnson COVID-19 vaccine booster in stores nationwide. The Food and Drug Administration’s recently authorized the Emergency Use of Pfizer and Moderna booster vaccines to individuals aged 18 and above, in addition to new guidance from the Centers for Disease Control and Prevention.
How to get in touch:
Appointments can be scheduled through the Walgreens app, by visiting Walgreens.com/ScheduleVaccine, or by calling 1-800-WALGREENS.
As per the Centers for Disease Control and Prevention (CDC) guidance, individuals 18 and older who have completed their Pfizer or Moderna primary vaccine dose at least six months ago, or for Johnson & Johnson dose at least two months ago, are now advised to receive a Pfizer, Moderna, or J&J COVID-19 vaccine booster shot.
Walgreen Boots Alliance (WBA) is a pharmacy-led, health and well-being enterprise with a long history of trusted healthcare services, community pharmacy care, and pharmaceutical wholesaling dates. To learn more about Walgreen Boots Alliance (WBA) and to continue to track its progress please visit the Vista Partners Walgreens Boots Alliance Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.